Cargando…

An atlas of the bone marrow bone proteome in patients with dysproteinemias

Multiple myeloma (MM) bone disease is a significant cause of morbidity but there is a paucity of data on the impact of malignant plasma cells on adjacent trabecular bone within the BM. Here, we characterize the proteome of trabecular bone tissue from BM biopsies of 56 patients with monoclonal gammop...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Matthew, Dasari, Surendra, Visram, Alissa, Drake, Matthew T., Charlesworth, M. Cristine, Johnson, Kenneth L., Pujari, Ganesh P., Jevremovic, Dragan, Kourelis, Taxiarchis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140150/
https://www.ncbi.nlm.nih.gov/pubmed/37105956
http://dx.doi.org/10.1038/s41408-023-00840-8
_version_ 1785033102599389184
author Ho, Matthew
Dasari, Surendra
Visram, Alissa
Drake, Matthew T.
Charlesworth, M. Cristine
Johnson, Kenneth L.
Pujari, Ganesh P.
Jevremovic, Dragan
Kourelis, Taxiarchis
author_facet Ho, Matthew
Dasari, Surendra
Visram, Alissa
Drake, Matthew T.
Charlesworth, M. Cristine
Johnson, Kenneth L.
Pujari, Ganesh P.
Jevremovic, Dragan
Kourelis, Taxiarchis
author_sort Ho, Matthew
collection PubMed
description Multiple myeloma (MM) bone disease is a significant cause of morbidity but there is a paucity of data on the impact of malignant plasma cells on adjacent trabecular bone within the BM. Here, we characterize the proteome of trabecular bone tissue from BM biopsies of 56 patients with monoclonal gammopathy of undetermined significance (MGUS), smoldering (SMM), newly diagnosed (NDMM), relapsed MM (RMM), and normal controls. Proteins involved in extracellular matrix (ECM) formation and immunity pathways were decreased in SMM and active MM. Among the proteins most decreased were immunoglobulins, type IV collagen, and TIMP3, suggesting increased immunoparesis and decreased ECM remodelling within trabecular bone. Proteins most increased in SMM/MM were APP (enhances osteoclast activity), ENPP1 (enhances bone mineralization), and MZB1 (required for normal plasmablast differentiation). Pathway analyses showed that proteins involved in gamma -carboxylation, a pathway implicated in osteocalcin function, osteoblast differentiation, and normal hematopoiesis, were also overexpressed in SMM/MM. This study is the first comprehensive proteomic atlas of the BM bone proteome in dysproteinemias. We identify new key proteins and pathways for MM bone disease and potentially impaired hematopoiesis, and show for the first time that gamma -carboxylation pathways are increased in the bone tissue of SMM/MM.
format Online
Article
Text
id pubmed-10140150
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-101401502023-04-29 An atlas of the bone marrow bone proteome in patients with dysproteinemias Ho, Matthew Dasari, Surendra Visram, Alissa Drake, Matthew T. Charlesworth, M. Cristine Johnson, Kenneth L. Pujari, Ganesh P. Jevremovic, Dragan Kourelis, Taxiarchis Blood Cancer J Article Multiple myeloma (MM) bone disease is a significant cause of morbidity but there is a paucity of data on the impact of malignant plasma cells on adjacent trabecular bone within the BM. Here, we characterize the proteome of trabecular bone tissue from BM biopsies of 56 patients with monoclonal gammopathy of undetermined significance (MGUS), smoldering (SMM), newly diagnosed (NDMM), relapsed MM (RMM), and normal controls. Proteins involved in extracellular matrix (ECM) formation and immunity pathways were decreased in SMM and active MM. Among the proteins most decreased were immunoglobulins, type IV collagen, and TIMP3, suggesting increased immunoparesis and decreased ECM remodelling within trabecular bone. Proteins most increased in SMM/MM were APP (enhances osteoclast activity), ENPP1 (enhances bone mineralization), and MZB1 (required for normal plasmablast differentiation). Pathway analyses showed that proteins involved in gamma -carboxylation, a pathway implicated in osteocalcin function, osteoblast differentiation, and normal hematopoiesis, were also overexpressed in SMM/MM. This study is the first comprehensive proteomic atlas of the BM bone proteome in dysproteinemias. We identify new key proteins and pathways for MM bone disease and potentially impaired hematopoiesis, and show for the first time that gamma -carboxylation pathways are increased in the bone tissue of SMM/MM. Nature Publishing Group UK 2023-04-28 /pmc/articles/PMC10140150/ /pubmed/37105956 http://dx.doi.org/10.1038/s41408-023-00840-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Ho, Matthew
Dasari, Surendra
Visram, Alissa
Drake, Matthew T.
Charlesworth, M. Cristine
Johnson, Kenneth L.
Pujari, Ganesh P.
Jevremovic, Dragan
Kourelis, Taxiarchis
An atlas of the bone marrow bone proteome in patients with dysproteinemias
title An atlas of the bone marrow bone proteome in patients with dysproteinemias
title_full An atlas of the bone marrow bone proteome in patients with dysproteinemias
title_fullStr An atlas of the bone marrow bone proteome in patients with dysproteinemias
title_full_unstemmed An atlas of the bone marrow bone proteome in patients with dysproteinemias
title_short An atlas of the bone marrow bone proteome in patients with dysproteinemias
title_sort atlas of the bone marrow bone proteome in patients with dysproteinemias
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140150/
https://www.ncbi.nlm.nih.gov/pubmed/37105956
http://dx.doi.org/10.1038/s41408-023-00840-8
work_keys_str_mv AT homatthew anatlasofthebonemarrowboneproteomeinpatientswithdysproteinemias
AT dasarisurendra anatlasofthebonemarrowboneproteomeinpatientswithdysproteinemias
AT visramalissa anatlasofthebonemarrowboneproteomeinpatientswithdysproteinemias
AT drakematthewt anatlasofthebonemarrowboneproteomeinpatientswithdysproteinemias
AT charlesworthmcristine anatlasofthebonemarrowboneproteomeinpatientswithdysproteinemias
AT johnsonkennethl anatlasofthebonemarrowboneproteomeinpatientswithdysproteinemias
AT pujariganeshp anatlasofthebonemarrowboneproteomeinpatientswithdysproteinemias
AT jevremovicdragan anatlasofthebonemarrowboneproteomeinpatientswithdysproteinemias
AT kourelistaxiarchis anatlasofthebonemarrowboneproteomeinpatientswithdysproteinemias
AT homatthew atlasofthebonemarrowboneproteomeinpatientswithdysproteinemias
AT dasarisurendra atlasofthebonemarrowboneproteomeinpatientswithdysproteinemias
AT visramalissa atlasofthebonemarrowboneproteomeinpatientswithdysproteinemias
AT drakematthewt atlasofthebonemarrowboneproteomeinpatientswithdysproteinemias
AT charlesworthmcristine atlasofthebonemarrowboneproteomeinpatientswithdysproteinemias
AT johnsonkennethl atlasofthebonemarrowboneproteomeinpatientswithdysproteinemias
AT pujariganeshp atlasofthebonemarrowboneproteomeinpatientswithdysproteinemias
AT jevremovicdragan atlasofthebonemarrowboneproteomeinpatientswithdysproteinemias
AT kourelistaxiarchis atlasofthebonemarrowboneproteomeinpatientswithdysproteinemias